Siebler, Philip H.
Heinze, Jared D.
Kienzle, Drake M.
Hale, Matthew W.
Lukkes, Jodi L.
Donner, Nina C.
Kopelman, Jared M.
Rodriguez, Orlando A.
Lowry, Christopher A. https://orcid.org/0000-0003-3920-5575
Funding for this research was provided by:
National Science Foundation (0845550)
Article History
Received: 3 July 2017
Accepted: 31 October 2017
First Online: 13 November 2017
Compliance with Ethical Standards
:
: Christopher A. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics Ltd. The remaining authors declare that they have no conflict of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All studies were consistent with the <i>National Institutes of Health Guide for the Care and Use of Laboratory Animals</i>, Eighth Edition (The National Academies Press, 2011), and the Institutional Animal Care and Use Committee at the University of Colorado Boulder approved all procedures. All possible efforts were made to minimize the number of animals used and their suffering.